1.
Clin Infect Dis
; 74(7): 1271-1274, 2022 04 09.
Article
in English
| MEDLINE | ID: covidwho-1706426
ABSTRACT
Twenty-five B-cell-depleted patients (24 following anti-CD19/20 therapy) diagnosed with coronavirus disease 2019 had been symptomatic for a median of 26 days but remained antibody negative. All were treated with convalescent plasma with high neutralizing antibody titers. Twenty-one (84%) recovered, indicating the potential therapeutic effects of this therapy in this particular population.
Subject(s)
COVID-19 , Antibodies, Neutralizing/therapeutic use , Antibodies, Viral , COVID-19/therapy , Humans , Immunization, Passive , SARS-CoV-2 , COVID-19 Serotherapy
2.
Leukemia
; 34(8): 2225-2229, 2020 08.
Article
in English
| MEDLINE | ID: covidwho-619295